Agenzia Italiana del Farmaco — Carenze (AIFA)
Agenzia Italiana del Farmaco — Carenze is the official source of medicine shortage information for Italy (EU). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.aifa.gov.it
- Country
- Italy
- Notices tracked by Mederti
- 5,064
- Last checked
- 1 Aug 2026
Latest notices from AIFA
- Bupivacaina Cloridrato — active, medium, since 1 Apr 2028 (source)
- Paracetamolo + Pseudoefedrina Cloridrato + Triprolidina Cloridrato — active, medium, since 31 Dec 2027 (source)
- Omeprazolo — active, medium, since 1 Jul 2027 (source)
- Cefotaxima Sodica — active, medium, since 1 Feb 2027 (source)
- Colecalciferolo — active, medium, since 30 Nov 2026 (source)
- Olmesartan Medoxomil — active, medium, since 20 Nov 2026 (source)
- Imatinib — active, medium, since 16 Nov 2026 (source)
- Etoposide — active, critical, since 2 Nov 2026 (source)
- Etoricoxib — active, medium, since 1 Nov 2026 (source)
- Esomeprazolo Sodico — active, medium, since 31 Oct 2026 (source)
- Mometasone Furoate — active, medium, since 31 Oct 2026 (source)
- Etoricoxib — active, medium, since 31 Oct 2026 (source)
- Idroclorotiazide + Irbesartan — active, medium, since 31 Oct 2026 (source)
- Colistimetato Sodico — active, medium, since 30 Oct 2026 (source)
- Tacrolimus-Monohydrate — active, medium, since 26 Oct 2026 (source)
Every AIFA notice, searchable and alertable
Search Italy's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Agenzia Italiana del Farmaco — Carenze. All notices remain the property of their publisher and are linked to the original source.